Table 1 The consumption of antifungal drugs in defined daily doses (DDD) and their percentage consumption from the corresponding antifungal class and the total antifungals consumption between 2004 and 2018
Antifungal class | Allylamines | Azoles | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Antifungal drug | Amorolfine | Naftifine | Clotrimazole | Econazole | Fenticonazole | Fluconazole | Isoconazole | Itraconazole | Ketoconazole | Omoconazole | Posaconazole | Sertaconazole | Miconazole | Voriconazole |
Total consumption in DDD | 32,610 | 310,539 | 5,261,955 | 520,317 | 1,841,725 | 6,723,869 | 70,913 | 4,005,650 | 2,279,202 | 29,097 | 7,644 | 209,932 | 2,570,771 | 48,587 |
Percentage of antifungal class consumption | 9.50% | 90.50% | 22.33% | 2.21% | 7.81% | 28.53% | 0.30% | 16.99% | 9.67% | 0.12% | 0.03% | 0.89% | 10.91% | 0.21% |
Percentage of total antifungals consumption | 0.1% | 0.97% | 16.42% | 1.62% | 5.75% | 20.99% | 0.22% | 12.5% | 7.11% | 0.09% | 0.02% | 0.66% | 8.02% | 0.15% |
Antifungal class | Polyenes | Echinocandins | Others | ||||
|---|---|---|---|---|---|---|---|
Antifungal drug | Amphotericin B | Nystatin | Anidulafungin | Caspofungin | Micafungin | Ciclopirox | Griseofulvin |
Total Consumption in DDD | 4,171 | 3,293,436 | 3,708 | 241 | 49 | 2,932,968 | 1,889,080 |
Percentage of Antifungal Class Consumption | 0.13% | 99.87% | 92.75% | 6.04% | 1.21% | 60.82% | 39.18% |
Percentage of Total Antifungals Consumption | 0.01% | 10.28% | 0.01% | 0.0008% | 0.0002% | 9.16% | 5.90% |